LumiraDx Limited (LMDXW) is a publicly traded company in the Healthcare sector, operating within the Medical - Diagnostics & Research industry. The company is headquartered in London, United Kingdom. The current CEO is Veronique Ameye EMBA,.
LMDXW has IPO date of 2021-09-29, 1,210 full-time employees, listed on the NASDAQ Global Market, a market capitalization of $5.1M.
LumiraDx Limited operates as a point of care diagnostic company. It focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. The company was formerly known as Point of Care Testing Limited and changed its name to LumiraDx Ltd in January 2018. LumiraDx Limited was incorporated in 2002 and is based in London, the United Kingdom.
